Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

8 Dec 2017 11:51

RNS Number : 8261Y
MJ Gleeson PLC
08 December 2017
 

8 December 2017

 

MJ Gleeson Plc

("the Company")

 

Notification of Transaction by Directors/PDMRs

 

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company announces that it was notified on 7 December 2017 that North Atlantic Smaller Companies Investment Trust PLC, part of Harwood Capital LLP, to which Christopher Mills, Director of this Company is a beneficiary, sold a total of 205,000 ordinary shares at an average price of 760.4244 pence per Ordinary Share. As a consequence of this transaction Mr. Mills is directly and indirectly interested, including those held by Related Persons, in 6,850,000 shares:

 

 

Shareholders

 

Shares Sold

 

Total held now

Percentage of Issued Share Capital

North Atlantic Smaller Companies Investment Trust plc

205,000

5,795,000

10.62%

Oryx International Growth Fund Ltd

0

1,000,000

1.83%

Harwood Capital LLP

0

55,000

0.10%

Total

 

6,850,000

12.55%

 

Following the above disposals, his current shareholdings, including those held by Related Persons, are as follows:

 

1.

Details of PDMR / person closely associated with them ('CAP')

a)

First Name

Christopher

b)

Last Name

Mills

2.

Reasons for the notification

a)

Position / status

Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

MJ Gleeson plc

b)

Legal Entity Identifier code

21380064K7N2W7FD6434

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of £0.02 each

GB00BRKD9Z53

b)

Nature of the transaction

Disposal via indirect holding through North Atlantic Smaller Companies Investment Trust PLC.

c)

 

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

£7.604244 per share

205,000 shares

d)

Aggregated information

- Aggregated volume

- Price

 

205,000

£7.604244 per share

e)

Date of the transaction

 

6 December 2017

 

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

S Allanson

Chief Financial Officer & Company Secretary

MJ Gleeson plc Tel: 01142 612900

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHTPBBTMBAMBMR
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.